Call for Abstracts

January 30 - February 1, 2025 | Walt Disney World Swan & Dolphin Resorts | Orlando, FL

NANS 2025 Abstract Submissions Are Now Closed

Thank you for submitting abstract(s) for the NANS 2025 Annual Meeting, held January 30 – February 1, 2025 at the Walt Disney World Swan & Dolphin Resorts in Orlando, FL.  

NANS 2025 is the premier meeting for neuromodulation that provides the opportunity to:

Gain visibility for your work.
Contribute to scientific advancements in the field of neuromodulation.
Enhance your professional network.

Submission Deadline

Thursday, August 15, 2024 at 1 PM Central Time (NOW CLOSED)

Abstract Categories

Scientific

This category may be considered for all presentation formats: Oral Presentation, Paper Poster Presentation or E-Poster.

Case reports/small series

This category will only be considered for a Paper Poster Presentation or an E-Poster.

Late-breaking abstracts

Only clinical trials will be considered for the Late-Breaking Abstract Category.
Abstract submission must be a prospective randomized controlled trial study.
The study must be ongoing at the time of initial submission.
Expect to have finalized data by Thursday, October 24, 2024.

Abstract Topics & Subtopics

Abstract submitters selecting Scientific Abstract or Case Reports/Small Series will need to select a topic and sub-topic. Below are the descriptions and list of topics and sub-topics.

advocacy and ethics

Industry Relationship
Conflict of Interest
Education
Pediatric Neuromodulation
Diversity
Other

basic science

No other subtopics

brain

Non-Invasive
Pain – Headache, DBS for other indication

Epilepsy
Movement Disorders
Psychiatric
Rehabilitation
Computer Interface
New Indications
ICV Drugs
Other

nerve

Headache
Genitourinary
GI
Pain
Systematic Disorder (RA, etc.)
Other

neural engineering

Devices (Design and Features)
Bio Interfaces
Neuroprosthetics
Software and Security

AI
Newer Technologies
Other

socioeconomics

Practice Management (reimburse-build)
Malpractice
Access
Contract Negotiation
Other

spine

Pain
IDDS
Spasticity
Cardiovascular
Restoration
New Indication (Parkinson’s Disease)
Other

other

Topics or subtopics that do not fit the above.

Session Formats

Submitters may indicate their preferred presentation format, but the assigned format is at the discretion of the Scientific Program Committee and Abstract Chairs.

Formats include the following:

ORAL PRESENTATION

The highest rated abstracts are selected for an Oral Presentation in a Concurrent Session. The highest-ranked Late-Breaking Abstracts are selected for an Oral Presentation. Oral presentations are awarded continuing medical education (CME) credits.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education the Presenting Author of an accepted abstract for an Oral Presentation cannot be an owner or employee of an ACCME-defined ineligible company.

Owners: are defined as individuals who have an ownership interest in a company, except for stockholders of publicly traded companies or holders of shares through a pension or mutual fund.
Employees: are defined as individuals hired to work for another person or business (the employer) for compensation and who are subject to the employer's direction as to the details of how to perform the job.
Ineligible Company(ies) is/are defined by ACCME) as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Examples of such organizations include:
- Advertising, marketing, or communication firms whose clients are ineligible companies
- Bio-medical startups that have begun a governmental regulatory approval process
- Compounding pharmacies that manufacture proprietary compounds
- Device manufacturers or distributors
- Diagnostic labs that sell proprietary products
- Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
- Manufacturers of health-related wearable products
- Pharmaceutical companies or distributors
- Pharmacy benefit managers
- Reagent manufacturers or sellers

Abstract submitters must make sure that the author they designate as the Presenting Author is not an owner or employee of an ineligible company.

PAPER POSTER
Highly-ranked abstracts accepted for Paper Poster Presentation will present their work on individually assigned poster boards during the interactive poster session.

The Presenting Author of an abstract accepted for a Paper Poster Presentation is responsible for printing the poster and bringing it with them to the meeting.
The Paper Poster Presentation is a non-CME session.

E-POSTERS
Some abstracts will only receive an acceptance or an Electronic Poster (E-poster). However, all accepted abstracts are required to submit an E-poster to be included in meeting publications.

There will not be moderated sessions or physical E-posters during the meeting. E-posters are available during the entirety of the NANS 2025 Annual Meeting in the meeting app. E-posters are non-CME.

All accepted abstracts will be published electronically following the meeting.

CME Guidelines for Abstracts and Education Sessions

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education Presenting Authors in Oral Abstracts, planners and/or faculty cannot be owners or employees of ineligible companies in continuing medical education activities.

Please review the NANS Policy on Financial Relationships with Ineligible Companies.

Submission Guidelines

Instructions with Screenshots

Please review the submission guidelines for more information prior to submitting your abstract.

REVIEW GUIDELINES

Please review the step-by-step instructions for submitting your abstract.

GET INSTRUCTIONS

Review Process

Abstracts submitted for the NANS 2025 Annual Meeting will go through a blind review process, by an independent scientific review committee and scored on scientific merit, originality, relevance to the field of neuromodulation. Although scientific data is important, the quality of the abstract is the primary determinant for acceptance by the NANS Scientific Program Committee.

Meeting Registration & Travel

The Presenting Author of an Oral Presentation, Paper Poster Presentation or an E-Poster must register to attend the NANS 2025 Annual Meeting for any accepted abstract to remain in the program. If the Presenting Author does not register for the meeting, then all abstracts by the Presenting Author will be declined.

Presenting Authors for all accepted abstracts are responsible for all expenses associated with attending the Annual Meeting, including:

Meeting registration
Travel
Housing
Paper Poster printing fees (if applicable)

Changing the Presenting Author of an Abstract
If you are not able to assume the responsibilities of Presenting Author, please complete the Change in Presenting Author Form by Friday, December 20, 2024. If you have any questions about the form, please contact Kim Stamp at [email protected].

After the change, all correspondence will then be sent to the new Presenting Author.

Important Dates

Abstract Submission Opening: Thursday, May 30, 2024

Abstract Submission Deadline: Thursday, August 15, 2024. Submission site closes at 1:00 PM Central Time.

October 2024:

Abstract acceptance notification emails will be sent out in October 2024.
Late-Breaking Abstracts: Emails requesting submission of updated data will be sent to the Abstract Submitter.
Thursday, October 24, 2024: Late-Breaking Abstract Data Submission Deadline. Site closes at 1:00 PM Central Time.

November 2024:

End of November: Late-Breaking Acceptance notifications emails will be sent to the Abstract Submitter

December 2024:

Change of presenting author deadline is Friday, December 20, 2024

January 2025:

Deadline for all E-Poster submissions is Monday, January 16, 2025
NANS 2025 Annual Meeting is Thursday, January 30 – Saturday, February 1, 2025

Questions?

If you have any other questions, please email Kim Stamp, NANS Educational Coordinator at [email protected].